sulfonamides / therapeutic use*

Explore academic connections and research related to this keyword

202
Views
6
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson P;Griffin I;Tucker C;Smith D;Oechsle O;Phelan A;Rawling M;Savory E;Stebbing J;;
2020 Lancet (London, England) 272 views
2
Treatment of bubonic plague with sulfonamides and antibiotics
SOKHEY SS;WAGLE PM;HABBU MK;;
1953 bulletin of the world health organization 219 views
3
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Jacobson IM;Lawitz E;Gane EJ;Willems BE;Ruane PJ;Nahass RG;Borgia SM;Shafran SD;Workowski KA;Pearlma...
2017 gastroenterology 277 views
4
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Asselah T;Kowdley KV;Zadeikis N;Wang S;Hassanein T;Horsmans Y;Colombo M;Calinas F;Aguilar H;de Ledin...
2018 clinical gastroenterology and hepatology : the off... 308 views
5
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
Forns X;Lee SS;Valdes J;Lens S;Ghalib R;Aguilar H;Felizarta F;Hassanein T;Hinrichsen H;Rincon D;Mori...
2017 The Lancet. Infectious Diseases 261 views
6
Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update
Kubo S;Nakayamada S;Tanaka Y;;
2019 expert review of clinical immunology 265 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE covid-19 sars-cov-2 humans pubmed abstract nih national institutes of health national library of medicine pandemics pneumonia letter viral / drug therapy* pmid:32032529 pmc7137985 doi:10.1016/s0140-6736(20)30304-4 peter richardson ivan griffin